Monday Lunch Livestream

with Associate Professor Jane Oliaro

12 December 2022

Immunotherapies take advantage of our immune system to fight cancer and have revolutionised modern cancer treatment.

Associate Professor Jane Oliaro presents us with research aimed at discovering new therapeutic targets to improve patient responses to immunotherapies.

The results of her lab's work highlight a role for tumour necrosis factor (TNF)-mediated bystander killing as a potent immune cell effector mechanism. The data generated also identifies new genes and pathways that may predict response to checkpoint blockade, or be therapeutically targeted to improve the number of patients that benefit from immunotherapy.